首页> 美国卫生研究院文献>International Journal of Health Policy and Management >Understanding the Battle for Universal Pharmacare in Canada Comment on Universal Pharmacare in Canada
【2h】

Understanding the Battle for Universal Pharmacare in Canada Comment on Universal Pharmacare in Canada

机译:了解加拿大普遍药品博战的战斗评论加拿大普遍的药店

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines is still organized as privileges offered by employers to their employees. Universal pharmacare would not only provide better access to needed prescription drugs, but also eliminate waste, ensure value-for-money and help improve drug safety and appropriate prescribing. Opponents fear that a universal pharmacare plan would ration drugs, and impede drug access for some patients. However, these claims misunderstand the reality of drug coverage, pricing and access. Opponents propose, instead, to "fill the gap" of current drug coverage by implementing catastrophic coverage, which would serve commercial interests without maximizing health outcomes for the Canadian population. In spite of overwhelming evidence and consensus in the academic community in favour of universal pharmacare, the battle is far from over.
机译:加拿大的药物报道是拼凑;不公平的低效和不可持续的拼凑而没有连贯或目的。有些人认为我们可以通过添加更多补丁来解决问题,但问题的核心是它是一个拼凑而成。对于工作人口,对药物的获取仍然被组织为雇主提供给员工的特权。 Universal Pharmacare不仅可以提供更好的获得所需的处方药,还可以消除浪费,确保资金价值,有助于提高药物安全和适当的处方。反对者担心,一个通用的药房计划将药物,并阻碍了一些患者的药物接入。然而,这些索赔误解了药物覆盖,定价和访问的现实。相反,对手通过实施灾难性的覆盖来说,“填补目前药物覆盖范围的差距”,这将提供商业利益,而不会最大化加拿大人口的健康结果。尽管在学术界的众多证据和共识支持普遍的药店,但战斗远非结束。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号